HESI will be attending the International Congress of Toxicology in Maastricht, Netherlands from 18-21 September 2022.
HESI at ICT2022 Symposium
September 18, 2022 – September 21, 2022
Maastricht, The Netherlands
The committee’s mission is to identify biomarkers for improving the prediction of neurotoxicity and seizurogenic compounds using microelectrode array (MEA).
This group is working toward identifying biomarkers of improving the prediction of neurotoxicity and identifying correlations in behavioral, imaging, and neuropathological endpoints. A phase 2
study was launched to validate a set of biomarkers of neurotoxicity.
This group is working toward characterizing the predictivity of seizurogenic activity using MEA technology. A final analysis of data generated from a multi-site study is expected by early 2023.
A subteam was formed to plan a small Think Tank workshop where participants will
discuss possible new areas of focus and next steps.
Associate Director for Program Development & Resourcing
jpierson@hesiglobal.orgU.S. Food & Drug Administration
ApconiX, Ltd.
No results.
September 18, 2022 – September 21, 2022
Maastricht, The Netherlands
HESI will be attending the International Congress of Toxicology in Maastricht, Netherlands from 18-21 September 2022.
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-3859
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.